September is National Childhood Cancer Awareness month, encouraging awareness and affirmation to the commitment of fighting pediatric cancer.
September 28, 2012
September 18, 2012
A once-promising discovery linking prostate cancer to an obscure retrovirus derived from mice was the result of an inadvertent laboratory contamination, a forensic analysis of tissue samples and lab experiments – some dating back nearly a decade – has confirmed.
September 13, 2012
Biomedical researchers at UCSF have won five of 51 prestigious National Institutes of Health Director’s New Innovator awards for high-risk, high-reward research, each receiving up to $1.5 million over five years.
August 21, 2012
A proposed new treatment to help HIV/AIDS patients suffering from Kaposi’s sarcoma, the most common form of cancer in people with HIV, is now one step closer to becoming a reality thanks to a program that supports promising early-stage research.
August 08, 2012
Preliminary results of a recent study by Christina Baggott, a trained oncology nurse, found that children with cancer were significantly more likely to weigh in on their symptoms when using a kid-friendly touch-screen computer assessment tool, than the standard written checklist.
August 07, 2012
Marin County, Calif., has one of the highest rates of breast cancer in the world, a fact that scientists know has nothing to do with the land itself but with some other, unknown factor.
July 24, 2012
A UCSF team has harnessed a natural protein in bacteria to create a “pause switch” in immune cells, potentially leading to more effective and safer immune therapies for diseases such as cancer and multiple sclerosis.
July 16, 2012
UCSF researchers triggered cellular transformation — and caused tumors to form in mice — by activating just two genes, a discovery that suggests drugs that are able to target those genes may provide a way to treat the deadly cancer, known as cholangiocarcinoma.
July 10, 2012
Cancer patients across the country have a new way to navigate through difficult treatment decisions and communicate better with their doctors. “Open to Options,’’ which recently launched nationally, was developed in conjunction with UCSF to guide patients in making critical health decisions.
July 01, 2012
People with lung cancer who are treated with the drug Tarceva face a daunting uncertainty: although their tumors may initially shrink, it's not a question of whether their cancer will return—it's a question of when. And for far too many, it happens far too soon.